Jubilant Life Sciences Limited
2.Tata Chemicals Limited
The overview for the stock Tata Chemicals is bullish. The stock surged around 10 per cent in last week in spite of the benchmark indices closing in the red. The stock was in a corrective fall from the high of 574.8 recorded on September 8. This fall halted at a low of 504 on September 29 and the stock had reversed higher thereafter. In a last week make new record high of 582 and also confirms the end of the corrective fall. A breakout inverted head and shoulder bullish pattern is also visible on the daily chart with a neckline at 555. A rise to test the next resistance at 585 is possible in the near-term. A strong break above this hurdle can take the stock higher to 600 or 610. Investors with a short-term perspective can buy the stock. Stop-loss can be placed at 550 for a target of 595. Revise the stop-loss higher to 571 as soon as the stock moves up to 590. The bullish outlook will get negated if the stock falls decisively below 555.3.Punjab National Bank
The stock Punjab National Bank looking positive in near term . The stock has been range bound between 132 and 150 for more than a month. Technically, the 100-week moving average at around 135 has been providing strong support and also limiting the downside all through the current consolidation phase. The stock rose 7-8 per cent in last week and is currently moving higher to test the upper end of the range. Inability to decisively break above 150 may retain the stock within the 132-150 range for some more time. However, the broader bias is bullish. There is a strong likelihood of the stock breaking the range above 150 in the coming days. Such a break can take the stock higher to 170 – the 61.8 per cent Fibonacci retracement resistance thereafter.4.SUNPHARMA
Sun Pharmaceuticals in last trading session there was not good moment seen and price closed at 749. Buy in Daily chart, there is a consolidation seen, and also there is a level of 750 from which if it get break in coming session then we seen the prices get breached to the level of 760. At level 818 there is a major consolidation, if it break that level it would b touch the level of 854 and may be it gives a new trend that is bullish. We can take the buy position; can breach upto the level of 760-765 and the risk part can be taken at below the level of 713.Sun Pharmaceutical Industries divestment of its seven prescription brands in India to RPG Life Sciences. This has been done after receiving approval of the Competition Commission of India and completion of all the necessary formalities for closure of the transaction. On July 27, 2016 Sun Pharma had informed the bourses that it had signed an agreement with RPG Life Sciences to divest seven prescription brands in India, owned by the company and its subsidiary, for a consideration of Rs 41 crore
5.CAIRN
Cairn India yesterday its was negative closing at level 233, But in daily chart it already gives the breakout of bullish pennant (continuation) pattern its long term trend is bullish. Investors can take the entry position from the short consolidation breakout level at 233.50 and in coming session it would be break the 52 week high. Pole of pennant pattern is near about 20%. So, we are expecting it would be further gives 15%-18% i.e. (level at 260) moment in this week. The resistance levels are 240-260 where profit booking will take place. Looking for down side 215 will be immediate support.Oil & gas exploration company Cairn India surpassed analysts’ expectations on quarterly earnings front Friday. Consolidated profit increased more than two-fold to Rs 778.7 cr, the highest in last six quarters, compared with Rs 359.55 cr in previous quarter, driven by strong operational performance & forex gain.
6.YESBANK
Long term trend of Yes Bank is bullish last week it performed well and gives mixed moment in intraday trading session due to its financial result. Analyzing weekly chart we feel cool up side in the prices of Yes Bank may lead to the level of 1360. Above this level we can expect to breach upto the level of 1365. Where a short down side support can take place at 1280.It estimated EPS CAGR of around 25 percent in FY17-19 (pre-dilution) after tweak-up by around 1 percent for FY17/18. Focus of the bank is on liability customer acquisitions and building a branchcentric model, thus moving toward a ‘retail’ model. The bank deferred its qualified institutional placement within 24 hours after being launched, citing extreme volatility & misinterpretation of new QIP guidelines. It was planning to raise USD 1 billion.
No comments:
Post a Comment